Company / Current Assets
Viking Therapeutics, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$715.6M
FY2025
5-year range
$167.0M / $907.2M
FY2021-FY2025
Trend
-21.1%
vs FY2024
Sector context
#80 of 213
Health Care
What the data says
At $716M, Viking Therapeutics, Inc.'s current assets ranks #80 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $14M in FY2016 to $907M in FY2024.
Based on SEC 10-K filings.
$716M in FY2025 with a 5-year CAGR of +22.8%.
Improved from $367M to $716M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +62.4%
- 5-Year CAGR
- +22.8%
- 10-Year CAGR
- -
Sector benchmark
#80 of 213 in Health CareTop 38% of 213This company $715.6M Sector average $2.5B
▼
-71.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +22.8%, indicating consistent growth.
- In FY2025, current assets decreased 21.1% year-over-year.
- Ranks #80 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $715.6M | -21.1% |
| FY2024 | $907.2M | +147.0% |
| FY2023 | $367.2M | +119.8% |
| FY2022 | $167.0M | -20.7% |
| FY2021 | $210.5M | -17.8% |
| FY2020 | $256.1M | -9.7% |
| FY2019 | $283.5M | -6.2% |
| FY2018 | $302.1M | +1282.7% |
| FY2017 | $21.9M | +56.4% |
| FY2016 | $14.0M | -8.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026